LONDON–(BUSINESS WIRE)–#RareDiseases–Technavio has published a new report on the drug development pipeline for dry age-related macular degeneration, including a study of the molecules.
Category: Business
Contact Lenses – World Markets to 2024: Analysis by Technology, Product, Design and Region – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Contact Lenses Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024” report has been added to ResearchAndMarkets.com’s offering. The report predicts the global contact lenses market to grow with a…
NIH Awards $6.5 Million to NDRI for Recovery of Human Tissues and Organs for Research
PHILADELPHIA–(BUSINESS WIRE)–The National Institutes of Health (NIH) have awarded $6,591,480 to the National Disease Research Interchange (NDRI) to support continued national leadership with the recovery and distribution of human organs and tissues for medical research. The five-year award of the Research Resource for Human Tissues and Organs (RRHTO) Cooperative Agreement funds NDRI’s Human Tissue and Organs for Research Resource (HTORR) Program. Established in 1987, the HTORR Program provide
Second Sight Completes $5.0 million Private Placement of Common Stock with Gregg Williams, Chairman of the Board of Directors
LOS ANGELES–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight” or “the Company”), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind patients, today announced that it has entered into a stock purchase agreement effective August 14, 2018 with entities beneficially owned by Gregg Williams, Chairman of the Board of Directors, for the purchase of 3,225,807 shares of commo
Sun Pharma Announces U.S. FDA Approval of CEQUA™ to Treat Dry Eye Disease
MUMBAI, India & PRINCETON, N.J.–(BUSINESS WIRE)–#Cequa–Sun Pharma announces U.S. FDA approval of CEQUA™ (cyclosporine ophthalmic solution) 0.09%, to treat Dry Eye Disease
Global Intraocular Lens Market Analysis, Trends, Market Size and Forecasts 2016-2024 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Intraocular Lens Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024” report has been added to ResearchAndMarkets.com’s offering. The report predicts the global intraocular lens market to grow wi…
Ophthalmology Picture Archiving and Communication System Market – Global Forecast to 2023 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Ophthalmology PACS (Picture Archiving and Communication System) Market by Type (Standalone, Integrated), Delivery (On-premise, Cloud), End User (Hospitals, Specialty Clinic, ASC), Region (North America (US, Canada) Europe,…
UnitedHealthcare Eye Care Program Gives Children Across the Country Access to Comprehensive Eye Exams and Glasses
MINNETONKA, Minn.–(BUSINESS WIRE)–UnitedHealthcare launched a new program to help improve access to comprehensive eye exams and prescription glasses for children across the country.
SciFluor Announces Appointment of Robert Dempsey to Board of Directors
CAMBRIDGE, Mass.–(BUSINESS WIRE)–SciFluor Life Sciences today announced that Robert Dempsey, MBA, has joined the Board of Directors.
Global Ophthalmology Devices Market Analysis & Forecast to 2024 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Ophthalmology Devices Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024” report has been added to ResearchAndMarkets.com’s offering. The report predicts the global ophthalmology devices market …
Aerie Pharmaceuticals Reports Topline Result from Rhopressa® Mechanism of Action Study
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, retina diseases and other diseases of the eye, today announced topline efficacy results from a double-masked, randomized, placebo-controlled study (AR-13324-CS206; NCT03233308) designed to evaluate the effect of Rhopressa® (netarsudil ophthalmi
Global Near-infrared Spectroscopy Market 2018-2022 – Evolution of Miniature NIR Spectrometers Gaining Momentum – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Near-infrared Spectroscopy Market 2018-2022” report has been added to ResearchAndMarkets.com’s offering. The Global Near-infrared Spectroscopy Market to grow at a CAGR of 9.16% during the period 2018-2022. Global Ne…
iSchemaView RAPIDTM Technology Now Installed in More Than 500 Stroke Centers — up 48 Percent Since April
REDWOOD CITY, Calif.–(BUSINESS WIRE)–iSchemaView announces that the RAPID platform is in use at more than 520 stroke centers, including 17 hospitals at Baylor Scott & White Health.
STAAR Surgical and Shinjuku LASIK Clinic in Japan Announce Strategic Cooperation Agreement
MONROVIA, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, and Dr. Maro Kariya of Shinjuku LASIK Clinic in Tokyo, today announced they have entered into a multi-year Strategic Cooperation Agreement to provide STAAR’s EVO Visian ICL™ intraocular lenses as a primary and premium option for patients seeking visual freedom from spectacles and contact lenses through refracti
Aerpio Reports Second Quarter 2018 Financial Results and Provides Business Update
CINCINNATI–(BUSINESS WIRE)–Aerpio Pharmaceuticals, Inc. (Nasdaq:ARPO), a biopharmaceutical company focused on advancing first-in-class treatments for ocular diseases, today reported financial results for the second quarter ended June 30, 2018 and provided a business update. “We had a busy and productive second quarter at Aerpio,” commented Stephen Hoffman, M.D. Ph.D., Chief Executive Officer of Aerpio. “Our ongoing TIME-2b study, evaluating the effect of AKB-9778, our first-in-class Tie2 acti
Verseon Interim Report Charts Progress of Development Programs as It Submits Phase I Protocol for Precision Anticoagulant
FREMONT, Calif.–(BUSINESS WIRE)–Verseon’s drug discovery program, based on an industry-leading in silico platform, progresses four programs with multiple novel compounds.
Choroidal Neovascularization | A Drug Pipeline Analysis Report 2018 | Technavio
LONDON–(BUSINESS WIRE)–#RareDiseases–Technavio has announced their latest pipeline analysis report on the drug pipeline for choroidal neovascularization.
Princeton Identity Iris Technology Featured in Samsung Galaxy Note9
HAMILTON, N.J.–(BUSINESS WIRE)–#Biometrics–Princeton Identity Iris Technology Featured in Samsung Galaxy Note9. Iris recognition technology offers increased convenience and security.
STAAR Surgical Announces Closing of Common Stock Offering
MONROVIA, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, announced today the closing of the previously announced underwritten public offering of 1,999,850 shares of its common stock, which includes the full exercise of the underwriter’s option to purchase up to an additional 260,850 shares, at a price to the public of $39.00 per share. The gross proceeds of the offer
Kala Pharmaceuticals Reports Second Quarter 2018 Financial Results
WALTHAM, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the development and commercialization of therapies using its proprietary mucus-penetrating particle (MPP) technology with an initial focus on the treatment of eye diseases, today reported financial results for the second quarter ended June 30, 2018. “Since our last update we have made excellent progress,” said Mark Iwicki, Chairman and Chief Executive Officer. “We have defined our s